Related Experiment Videos
Abstract:
The increased incidence of invasive candidosis in numerous categories of patients, including neonates, cancer patients, AIDS patients and patients who have undergone organ transplantation, is of great concern for the physicians involved. The manifestations of candidosis are numerous, and various clinical entities such as localized and disseminated infection have to be considered separately. All types of localized candidosis per se are usually not the main cause of disseminated disease. However, spreading of the mycotic pathogens in the gastrointestinal tract could induce disseminated candidosis. Prophylactic measurements in risk patients and consequent local and, if necessary, systemic treatment is recommended in these clinical entities.
Insights
Invasive candidosis is rising in vulnerable patients like neonates and those with cancer or AIDS. Early prophylaxis and treatment are crucial to prevent severe, disseminated infections, especially from gastrointestinal spread.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Critical Care Medicine
Background:
- Invasive candidosis incidence is increasing across diverse patient populations.
- High-risk groups include neonates, cancer patients, AIDS patients, and organ transplant recipients.
- Physicians face significant challenges managing this opportunistic fungal infection.
Purpose of the Study:
- To highlight the growing concern of invasive candidosis.
- To differentiate between localized and disseminated forms of candidosis.
- To emphasize the importance of prophylactic and therapeutic strategies.
Main Methods:
- Review of clinical manifestations and risk factors for invasive candidosis.
- Analysis of potential routes for disease dissemination, particularly from the gastrointestinal tract.
- Evaluation of current management recommendations.
Main Results:
- Localized candidosis typically does not lead to disseminated disease.
- Gastrointestinal tract candidal pathogen spread is a significant pathway to disseminated infection.
- Specific patient categories exhibit increased susceptibility.
Conclusions:
- Prophylactic measures are essential for at-risk patients.
- Prompt local and systemic treatment is recommended for candidosis.
- Understanding disease pathways is key to effective patient management.